These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8760368)

  • 1. Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins.
    Marcinkiewicz C; Rosenthal LA; Mosser DM; Kunicki TJ; Niewiarowski S
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):817-25. PubMed ID: 8760368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 and alpha(v) beta3 integrins and expression of ligand-induced binding site.
    Marcinkiewicz C; Vijay-Kumar S; McLane MA; Niewiarowski S
    Blood; 1997 Aug; 90(4):1565-75. PubMed ID: 9269775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
    McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S
    FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit.
    Juliano D; Wang Y; Marcinkiewicz C; Rosenthal LA; Stewart GJ; Niewiarowski S
    Exp Cell Res; 1996 May; 225(1):132-42. PubMed ID: 8635506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model.
    Beviglia L; Stewart GJ; Niewiarowski S
    Oncol Res; 1995; 7(1):7-20. PubMed ID: 7549046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets.
    McLane MA; Kowalska MA; Silver L; Shattil SJ; Niewiarowski S
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):429-36. PubMed ID: 8042985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins.
    Wierzbicka-Patynowski I; Niewiarowski S; Marcinkiewicz C; Calvete JJ; Marcinkiewicz MM; McLane MA
    J Biol Chem; 1999 Dec; 274(53):37809-14. PubMed ID: 10608843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition.
    Pfaff M; McLane MA; Beviglia L; Niewiarowski S; Timpl R
    Cell Adhes Commun; 1994 Dec; 2(6):491-501. PubMed ID: 7538018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.
    Deckmyn H; Stanssens P; Hoet B; Declerck PJ; Lauwereys M; Gansemans Y; Tornai I; Vermylen J
    Br J Haematol; 1994 Jul; 87(3):562-71. PubMed ID: 7993797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa.
    Calvete JJ; McLane MA; Stewart GJ; Niewiarowski S
    Biochem Biophys Res Commun; 1994 Jul; 202(1):135-40. PubMed ID: 8037704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
    Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
    J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
    Lele M; Sajid M; Wajih N; Stouffer GA
    Circulation; 2001 Jul; 104(5):582-7. PubMed ID: 11479257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S; Flynn G; Aitken A; Patel Y; Hussain F; Lu X; Loftus JC; French D; Wijelath E; Strand K; Savidge GF
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells.
    Danen EH; Marcinkiewicz C; Cornelissen IM; van Kraats AA; Pachter JA; Ruiter DJ; Niewiarowski S; van Muijen GN
    Exp Cell Res; 1998 Jan; 238(1):188-96. PubMed ID: 9457071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet integrin alpha IIb beta 3 (GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets.
    Pedreño J; Fernández R; Cullaré C; Barceló A; Elorza MA; de Castellarnau C
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):156-63. PubMed ID: 9012651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function.
    McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S
    Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study.
    Yahalom D; Wittelsberger A; Mierke DF; Rosenblatt M; Alexander JM; Chorev M
    Biochemistry; 2002 Jul; 41(26):8321-31. PubMed ID: 12081480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
    Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
    Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
    Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
    J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.